Ukr.Biochem.J. 2024; Volume 96, Issue 3, May-Jun, pp. 66-74

doi: https://doi.org/10.15407/ubj96.03.066

Non-coding RNA NEAT-1 and interleukin-6 as diagnostic indicators for vitiligo

12.06.2024   Uncategorized   No comments

Mai M. Sharabi1*, Amr A. Zahra1, Azza M. Elamir1,
Talal A. Abd El Raheem2, Nesreen M. Aboraia2

1Department of Medical Biochemistry and Molecular Biology,
Faculty of Medicine, Fayoum University, Fayoum, Egypt;
2Department of Dermatology, STDs Andrology, Faculty of Medicine,
Fayoum University, Fayoum, Egypt;
*e-mail: mmm29@fayoum.edu.eg

Received: 15 March 2024; Revised: 23 April 2024;
Accepted: 31 May 2024; Available on-line: 17 June 2024

Vitiligo belongs to chronic autoimmune diseases and results in a loss of functioning melanocytes and skin depigmentation. Nuclear enriched abundant transcript 1 (NEAT-1) is a long non-coding RNA that has a vital role in the diagnostics and treatment of certain autoimmune and inflammatory diseases. It is suggested that NEAT-1 can increase the pro-inflammatory cytokine level via regulatory network. The aim of the work was to measure the serum level of NEAT-1 and IL-6 in vitiligo patients compared with healthy controls and to estimate its relation to disease activity. In the study, 60 individuals were enrolled subdivided into 40 vitiligo patients and 20 healthy controls of similar age and gender. NEAT-1 expression was detected by Quantitative real-time PCR, and IL-6 level was measured by ELISA. To assess the severity of the disease Vitiligo area scoring index (VASI) was calculated. Results showed that there was a significant increase in both NEAT-1 and IL-6 levels in vitiligo patients compared with the control group. A positive correlation between NEAT-1 and IL-6 levels­ and a negative correlation between NEAT-1 level and VASI score was revealed. The elevated serum levels­ of NEAT-1 and IL-6 suggest that these circulating biomarkers have promise as diagnostic indicators for vitiligo and possible targets for therapeutic interventions.

Keywords: , , , ,

References:

  1. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clin Rev Allergy Immunol. 2018;54(1):52-67. PubMed, CrossRef
  2. Pang K, Xiao Y, Li L, Chen X, Wei G, Qian X, Li T , Guo Y, Chen J, Tang Y. LncRNA-mRNA co-expression network revealing the regulatory roles of lncRNAs in melanogenesis in vitiligo. J Hum Genet. 2022;67(5):247-252. PubMed, CrossRef
  3. Mansuri MS, Singh M, Dwivedi M, Laddha NC, Marfatia YS, Begum R. MicroRNA profiling reveals differentially expressed microRNA signatures from the skin of patients with nonsegmental vitiligo. Br J Dermatol. 2014;171(5):1263-1267. PubMed, CrossRef
  4. Wang LK, Chen XF, He DD, Li Y, Fu J. Dissection of functional lncRNAs in Alzheimer’s disease by construction and analysis of lncRNA-mRNA networks based on competitive endogenous RNAs. Biochem Biophys Res Commun. 2017;485(3):569-576. PubMed, CrossRef
  5. Lodde V, Murgia G, Simula ER, Steri M, Floris M, Idda ML. Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases. Biomolecules. 2020;10(7):1044. PubMed, PubMedCentral, CrossRef
  6. Sasaki YTF, IdeueT, Sano M, Mituyama T, Hirose T. MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proc Natl Acad Sci USA. 2009;106(8):2525-2530. PubMed, PubMedCentral, CrossRef
  7. Shui X, Chen S, Lin J, Kong J, Zhou C, Wu J. Knockdown of lncRNA NEAT1 inhibits Th17/CD4+ T cell differentiation through reducing the STAT3 protein level. J Cell Physiol. 2019;234(12):22477-22484. PubMed, CrossRef
  8. Zhang F, Wu L, Qian J, Qu B , Xia S, La T, Wu Y, Ma J, Zeng J, Guo Q, Cui Y, Yang W, Huang J, Zhu W, YaoY, Shen N, Tang Y. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. J Autoimmun. 2016;75:96-104. PubMed, CrossRef
  9. Wang R, Xue S, Liu Y, Peng M, Guo B. The correlation of long non-coding RNA NEAT1 and its targets microRNA (miR)-21, miR-124, and miR-125a with disease risk, severity, and inflammation of allergic rhinitis. Medicine (Baltimore). 2021;100(4):e22946. PubMed, PubMedCentral, CrossRef
  10. 1Yang J, Wang S, Liu L, Wang J, Shao Y. Long non-coding RNA NEAT1 and its targets (microRNA-21 and microRNA-125a) in rheumatoid arthritis: Altered expression and potential to monitor disease activity and treatment outcome. J Clin Lab Anal. 2021;35(12):e24076. PubMed, PubMedCentral, CrossRef
  11. Tackey E, Lipsky PE, Illei GG. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 2004;13(5):339-343. PubMed, PubMedCentral, CrossRef
  12. Singh M, Jadeja SD, Vaishnav J, Mansuri MS, Shah C, Mayatra JM, Shah A, Begum R. Investigation of the Role of Interleukin 6 in Vitiligo Pathogenesis. Immunol Invest. 2022;51(1):120-137. PubMed, CrossRef
  13. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140(6):677-683. PubMed, CrossRef
  14. Dicle O. Assessment Methods in Vitiligo. J Pigment Disord. 2015; 2(160):2376-2427. CrossRef
  15. Rodrigues M, Ezzedine K., Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77(1):1-13. PubMed, CrossRef
  16. Zhang L, Zhang Z, Yu Z. Long non-coding RNA NEAT1 can predict various malignant tumour lympha node metastasis: a meta-analysis. Artif Cells Nanomed Biotechnol. 2019;47(1):2516-2520. PubMed, CrossRef
  17. Prinz F, Kapeller A, Pichler M, Klec C. The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases. Int J Mol Sci. 2019;20(3):627. PubMed, PubMedCentral, CrossRef
  18. Singh RK, Lee KM, Vujkovic-Cvijin I, Ucmak D, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Bhutani T, Wei M, Liao W. The role of IL-17 in vitiligo: A review. Autoimmun Rev. 2016;15(4):397-404. PubMed, PubMedCentral, CrossRef
  19. Dastmalchi R, Ghafouri-Fard S, Omrani MD, Mazdeh M, Sayad A, Taheri M. Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients. Mult Scler Relat Disord. 2018;25:219-226. PubMed, CrossRef
  20. Mohammed SR, Abdelaleem OO, Ahmed FA, Abdelaziz AA, Hussein HA, Eid HM, Kamal M, Ezzat MA, Ali MA. Expression of lncRNAs NEAT1 and lnc-DC in Serum From Patients With Behçet’s Disease Can Be Used as Predictors of Disease. Front Mol Biosci. 2022;8:797689. PubMed, PubMedCentral, CrossRef
  21. Mohammed A, Shaker OG, Khalil MAF, ElsabaghYA, Gomaa M, Ahmed AM, Erfan R. Association of long non-coding RNAs NEAT1, and MALAT1 expression and pathogenesis of Behçet’s disease among Egyptian patients. Saudi J Biol Sci. 2022;29(8):103344. PubMed, PubMedCentral, CrossRef
  22. Chatterjee S, Bhattcharjee D, Misra S, Saha A, Bhattacharyya NP, Ghosh A. Increase in MEG3, MALAT1, NEAT1 significantly predicts the clinical parameters in patients with rheumatoid arthritis. Per Med. 202;17(6):445-457. PubMed, CrossRef
  23. Zailaie MZ. Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment. Saudi Med J. 2005;26(5):799-805. PubMed
  24. Wańkowicz-Kalińska A, van den Wijngaard RM, Tigges BJ, Westerhof W, Ogg GS, Cerundolo V, Storkus WJ, Das PK. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest. 2003;83(5):683-695. PubMed, CrossRef
  25. Karagün E, Baysak S. Levels of TNF-α, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo. Aging Male. 2020;23(5):1487-1492. PubMed, CrossRef
  26. Tomaszewska K, Kozłowska M, Kaszuba A, Lesiak A, Narbutt J, Zalewska-Janowska A. Increased Serum Levels of IFN- γ, IL-1 β, and IL-6 in Patients with Alopecia Areata and Nonsegmental Vitiligo. Oxid Med Cell Longev. 2020;2020:5693572. PubMed, PubMedCentral, CrossRef
  27. Kovacs D, Bastonini E, Ottaviani M, Cota C, Migliano E, Dell’Anna ML, Picardo M. Vitiligo Skin: Exploring the Dermal Compartment. J Invest Dermatol. 2018;138(2):394-404. PubMed, CrossRef
  28. Zaki AM, Abd El Aziz HM, Mohamed MA, Abd El Hamed AAM. Evaluation of Serum Interleukin-6 Level in Vitiligo Patients before and after Phototherapy. Egyptian J Hospital Med. 2019;77(3):5276-5278. CrossRef
  29. Chen J, Luo X, Liu M, Peng L, Zhao Z, He C, He Y. Silencing long non-coding RNA NEAT1 attenuates rheumatoid arthritis via the MAPK/ERK signalling pathway by downregulating microRNA-129 and microRNA-204. RNA Biol. 2021;18(5):657-668. PubMed, PubMedCentral, CrossRef
  30. Xu Y, Cao Z, Ding Y, Li Z, Xiang X, Lai R, Sheng Z, Liu Y, Cai W, Hu R, Wang H, Xie Q. Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response. Front Physiol. 2019;10:1503. PubMed, PubMedCentral, CrossRef
  31. Sun L, Sun J, Huo X , Feng Q, Li Y, Xie X, Geng S. Lipopolysaccharide reduces melanin synthesis in vitiligo melanocytes by regulating autophagy. Exp Dermatol. 2022;31(10):1579-1585. PubMed, CrossRef
  32. Al Houssien AO, Al Houssien RO, Al Ajroush W, Al Kahtani HS. Chronic diseases among vitiligo patients. A case control study. Saudi Med J. 2017;38(4):400-404. PubMed, PubMedCentral, CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.